Nutritional Effects on Host Response to Lung Infections with Mucoid Pseudomonas aeruginosa in Mice
Open Access
- 1 March 2004
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (3), 1479-1486
- https://doi.org/10.1128/iai.72.3.1479-1486.2004
Abstract
In cystic fibrosis, a recessive genetic disease caused by defects in the cystic fibrosis conductance regulator (CFTR), the main cause of death is lung infection and inflammation. Nutritional deficits have been proposed to contribute to the excessive host inflammatory response in both humans and Cftr -knockout mice. Cftr -knockout mice and gut-corrected Cftr -knockout mice expressing human CFTR primarily in the gut were challenged with Pseudomonas aeruginosa -laden agarose beads; they responded similarly with respect to bronchoalveolar lavage cell counts and levels of the acute-phase cytokines tumor necrosis factor alpha, interleukin-1β (IL-1β), and IL-6. Wild-type mice fed the liquid diet used to prevent intestinal obstruction in Cftr -knockout mice had inflammatory responses to P. aeruginosa -laden agarose beads similar to those of wild-type mice fed an enriched solid diet, so dietary effects are unlikely to account for differences between wild-type mice and mice with cystic fibrosis. Finally, since cystic fibrosis patients and Cftr -knockout mice have an imbalance in fatty acids (significantly lower-than-normal levels of docosahexaenoic acid), the effects of specific supplementation with docosahexaenoic acid of wild-type and Cftr -knockout mice on their inflammatory responses to P. aeruginosa -laden agarose beads were tested. There were no significant differences ( P = 0.35) in cumulative survival rates between Cftr -knockout mice and wild-type mice provided with either the liquid diet Peptamen or Peptamen containing docosahexaenoic acid. In conclusion, diet and docosahexaenoic acid imbalances alone are unlikely to explain the differences in the host response to lung infections with mucoid P. aeruginosa between mice with cystic fibrosis and their wild-type counterparts.Keywords
This publication has 29 references indexed in Scilit:
- Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronicPseudomonas aeruginosalung infectionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- Innate Lung Defenses and CompromisedPseudomonas aeruginosaClearance in the Malnourished Mouse Model of Respiratory Infections in Cystic FibrosisInfection and Immunity, 2000
- Evidence for the Presence of Peroxisome Proliferator-activated Receptor (PPAR) α and γ and Retinoid Z Receptor in CartilageJournal of Biological Chemistry, 2000
- Activation of Human T Lymphocytes Is Inhibited by Peroxisome Proliferator-activated Receptor γ (PPARγ) AgonistsJournal of Biological Chemistry, 2000
- Aerosolization of Low Phase Transition Temperature Liposomal Tobramycin as a Dry Powder in an Animal Model of Chronic Pulmonary Infection Caused byPseudomonas aeruginosaJournal of Drug Targeting, 1999
- Activation of Proliferator-activated Receptors α and γ Induces Apoptosis of Human Monocyte-derived MacrophagesJournal of Biological Chemistry, 1998
- Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa.JCI Insight, 1997
- A comparison of the effects of linolenic (18:3Ω3) and docosahexaenoic (22:6Ω3) acids on phospholipid bilayersChemistry and Physics of Lipids, 1990
- Prostaglandins, Arachidonic Acid, and InflammationScience, 1980